Skip to main content

YMAB

Stock
Health Care
Biotechnology

Performance overview

YMAB Price
Price Chart

Forward-looking statistics

Beta
1.48
Risk
64.55%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

Company info

SectorHealth Care
IndustryBiotechnology
Employees110
Market cap$525.7M

Fundamentals

Enterprise value$144.5M
Revenue$88.7M
Revenue per employee—
Profit margin-31.85%
Debt to equity0.67

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.64
Dividend per share—
Revenue per share$1.99
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$2M
Put-call ratio—

Macro factor sensitivity

Growth+14.0
Credit-6.3
Liquidity-6.4
Inflation+10.3
Commodities+5.9
Interest Rates-2.8

Valuation

Dividend yield0.00%
PEG Ratio-7.41
Price to sales2.20
P/E Ratio-7.41
Enterprise Value to Revenue1.63
Price to book2.18

Upcoming events

Next earnings dayMay 13, 2025
Next dividend day—
Ex. dividend day—

News

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates

Y-mAbs Therapeutics, Inc. (YMAB) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.15 per share a year ago.

Zacks Investment Research (May 13, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free